No. | Sex | Age (years) | Symptoms | Abnormal finding at screening examination | Examinations | Diagnosis | Therapy | Eligibility for sport |
---|---|---|---|---|---|---|---|---|
1 | M | 18 | N | ECG | E, Ex, H, Ad, EP | WPW | Ab | Y |
2 | M | 28 | N | ECG | E, Ex, H, Ad | WPW | N | Y |
3 | M | 32 | N | ECG | E, Ex, H, Ad | WPW | N | Y |
4 | F | 18 | N | ECG | E, Ex, H, ECG, G | LQTS 1 | BB | N |
5 | M | 20 | N | FH (BAV family) | E | BAV | N | Y |
6 | M | 25 | N | PE (murmur) | E | BAV, AR 2+ | N | Y |
7 | M | 21 | N | PE (murmur) | E | BAV, AR 2+ | N | Y |
8 | M | 34 | N | PE (murmur) | E, Ex | MVP, MR 2+ | N | Y |
9 | M | 33 | N | PE (murmur) | E, Ex | MVP, MR 2+ | N | Y |
10 | M | 27 | N | PE (HTA) | BPM, E | HTA | N | Y |
11 | M | 14 | Y | H (palpitations) | E, Ex, H | AT | N | Y |
Ab, radiofrequency ablation of the accessory pathway; Ad, ECG with exposure to adenosine; AR 2+, mild aortic regurgitation; AT, atrial tachycardia; BAV, bicuspid aortic valve; BB, β-blockers; BPM, 24 h blood pressure monitoring; E, echocardiogram; Ex, exercise stress test; F, female; FH, family history; G, genetic testing; H, history; HTA, systemic hypertension; H, 24 h Holter monitoring; LQTS 1, long QT syndrome type 1; M, male; MVP, mitral valve prolapse; MR 2+, mild mitral regurgitation; N, no; PE, physical examination; WPW, Wolff-Parkinson-White; Y, yes.